The mRNA Patent and Competitive Landscape: Pioneers, Litigation Outlook and Big Pharma’s Next Moves (Part III)
The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)
The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I
IP Assignment Considerations for Emerging Companies
Dana-Farber Launches New Fund to Support Oncology Startups
Hyundai Buys Majority of Boston Dynamics from SoftBank in $1.1B deal
Emerging Companies: Framework for Leveraging Your IP & Tech
COVID-19 Vaccine Leader Moderna “Not Aware of Any Significant Intellectual Property Impediments” in Development of its Vaccine Despite Mixed Results at PTAB
